Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call

        Print
| Source: Onconova Therapeutics

NEWTOWN, Pa., March 4, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that financial results for the Company's fourth quarter and year ended December 31, 2013 will be released on Monday, March 10, 2014. The Company will host a conference call and audio webcast at 4:30 PM ET on the same day.

Conference Call and Webcast Details:

Date: March 10, 2014  
Time: 4:30 PM ET  
Toll-free: (877) 312-5881  
International: (253) 237-1173  
Conference ID: 9033414  
Live webcast: investor.onconova.com or click here

A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the Company's website for two weeks following the call.

About Onconova Therapeutics, Inc.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. Onconova's clinical and pre-clinical stage drug development candidates are derived from its extensive chemical library and are designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. In addition to rigosertib, the Company's most advanced product candidate, two other candidates are in clinical trials, and several candidates are in pre-clinical stages.  For more information, please visit http://www.onconova.com

Onconova Therapeutics
Benjamin Hoffman, 267-759-3680


or

Media:
MacDougall Biomedical Communications
Chris Erdman, 781-235-3060